R4 Ballot #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

11.11.1 Resource MedicinalProductIndication - Maturity Dependency View

Biomedical Research and Regulation Work GroupMaturity Level: 0 Trial Use Compartments: Not linked to any defined compartments

Dependency Graph for MedicinalProductIndication FMM level 0

NameCard.TypeDependency Analysis
.. MedicinalProductIndication DomainResource
... subject 0..*Reference(MedicinalProduct | Medication)
... diseaseSymptomProcedure 0..1CodeableConcept
... diseaseStatus 0..1CodeableConcept
... comorbidity 0..*CodeableConcept
... intendedEffect 0..1CodeableConcept
... duration 0..1Quantity
... otherTherapy 0..*BackboneElement
.... therapyRelationshipType 1..1CodeableConcept
.... medication[x] 1..1
..... medicationCodeableConceptCodeableConcept
..... medicationReferenceReference(MedicinalProduct | Medication | Substance | SubstanceSpecification
... undesirableEffect 0..*Reference(MedicinalProductUndesirableEffect)
... population 0..*BackboneElement
.... age[x] 0..1
..... ageRangeRange
..... ageCodeableConceptCodeableConcept
.... gender 0..1CodeableConcept
.... race 0..1CodeableConcept
.... physiologicalCondition 0..1CodeableConcept